Financials United Orthopedic Corporation

Equities

4129

TW0004129002

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange 06:00:00 2024-05-23 pm EDT 5-day change 1st Jan Change
94.7 TWD +2.82% Intraday chart for United Orthopedic Corporation -3.76% +11.28%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024
Capitalization 1 3,270 2,461 3,734 7,445 9,137
Enterprise Value (EV) 1 3,270 2,461 3,734 7,445 9,137
P/E ratio 39.4 x - - - -
Yield - - 5.23% 4.7% 5.28%
Capitalization / Revenue - 0.96 x 1.18 x 1.89 x 1.93 x
EV / Revenue - 0.96 x 1.18 x 1.89 x 1.93 x
EV / EBITDA - - - - -
EV / FCF - 16.2 x 53.2 x -102 x 17.2 x
FCF Yield - 6.19% 1.88% -0.98% 5.82%
Price to Book - - 1.25 x 2.13 x 2.31 x
Nbr of stocks (in thousands) 88,390 78,112 78,112 87,481 96,487
Reference price 2 37.00 31.50 47.80 85.10 94.70
Announcement Date 3/29/21 3/29/22 3/28/23 3/21/24 -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024
Net sales 1 - 2,571 3,169 3,930 4,745
EBITDA - - - - -
EBIT 1 - 161.4 341.6 543.3 720
Operating Margin - 6.28% 10.78% 13.82% 15.17%
Earnings before Tax (EBT) - - - - -
Net income 101.8 - - - -
Net margin - - - - -
EPS 0.9400 - - - -
Free Cash Flow 1 - 152.3 70.16 -72.65 532
FCF margin - 5.93% 2.21% -1.85% 11.21%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share 2 - - 2.500 4.000 5.000
Announcement Date 3/29/21 3/29/22 3/28/23 3/21/24 -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 739.8 744 928.1 933.3 934.4 1,134 1,066 1,180 1,130 1,368
EBITDA - - - 211.4 273.5 - - - - -
EBIT 1 60.92 71.54 101.8 114.6 171.2 155.8 124.9 182 188 226
Operating Margin 8.24% 9.62% 10.96% 12.28% 18.32% 13.73% 11.72% 15.42% 16.64% 16.52%
Earnings before Tax (EBT) - - - - - - - - - -
Net income - - - - - - - - - -
Net margin - - - - - - - - - -
EPS - - - - - - - - - -
Dividend per Share - - - - - - - - - -
Announcement Date 5/16/22 8/15/22 5/15/23 8/14/23 11/14/23 3/21/24 5/15/24 - - -
1TWD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - 152 70.2 -72.7 532
ROE (net income / shareholders' equity) - - - 11.8% 13.6%
ROA (Net income/ Total Assets) - - - 6.39% 7.41%
Assets - - - - -
Book Value Per Share 2 - - 38.30 39.90 41.10
Cash Flow per Share - - - - -
Capex 1 - 190 287 506 400
Capex / Sales - 7.38% 9.05% 12.89% 8.43%
Announcement Date 3/29/21 3/29/22 3/28/23 3/21/24 -
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
94.7 TWD
Average target price
124 TWD
Spread / Average Target
+30.94%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4129 Stock
  4. Financials United Orthopedic Corporation